Clinical Trials Browser

Phase 1/2 × Terminated × donafenib × Clear all

NCT02489201 2023-06-15

A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer

Phase 1/2 Terminated

Gastrointestinal

Esophageal Neoplasms

NCT02489214 2023-05-08

Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer

Phase 1/2 Terminated

Gastrointestinal

Stomach Neoplasms

NCT02698111 2023-05-08

Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma

Phase 1/2 Terminated

Nasopharyngeal Carcinoma